HIGHLIGHTS
- who: IgG and colleagues from the Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom have published the research: Mouse IgG2a isotype therapeutic antibodies elicit superior tumor growth control compared to mIgG1 or mIgE, in the Journal: (JOURNAL) of 10/01/2023
- what: The aim of this study was to compare the in_vivo efficacy of tumor-targeting antibodies of different isotypes in a therapeutic setting. The authors directly compared the therapeutic activity of murine IgG2a, IgG1 and IgE bearing syngeneic B16-OVA-Thy1.1 tumors were used for . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.